Genetic polymorphisms in glutathione S-transferases T1, M1 and P1 and susceptibility to reflux esophagitis

Diseases of the Esophagus

Volumn 19, Issue 6, 2006, Pages 477-481

  Liu, B ^a   Fan, Y J ^a   Wang, M L ^a   Lu X D ^b   Jiang, J L ^a   Wang, T Y ^a   Fan, Z M ^b   Wang, J K ^b   Wang, L D ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Genetic polymorphisms; GSTM1; GSTP1; GSTT1; H. pylori; Reflux esophagitis

Indexed keywords

GENOMIC DNA; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CASE CONTROL STUDY; CHINA; CIGARETTE SMOKING; CODON; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA EXTRACTION; ESOPHAGUS BIOPSY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NUCLEIC ACID BASE SUBSTITUTION; PERIPHERAL LYMPHOCYTE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; REFLUX ESOPHAGITIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE;

CASE-CONTROL STUDIES; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGITIS, PEPTIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 33750444237     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2006.00609.x     Document Type: Article

References (31)

1. Dent J, Brun J, Fendrick A M et al. An evidence-based appraisal of reflux disease management-the Genval Workshop Report. Gut 1999; 44: S1-16.
2. Benjamin C Y W, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006; 4: 398-407.
3. Kang J Y, Tay H H, Yap I et al. Low frequency of endoscopic esophagitis in Asian patients. J Clin Gastroenterol 1993; 16: 70-3.
4. Pera M, Cameron A, Trastek V F et al. Increasing incidence of adenocarcinoma of the esophagus and esophago-gastic junction. Gastroenterol 1993; 104: 510-13.
5. Pan G, Xu G, Ke M et al. Epidemiological study of symptomatic gastroesophageal reflux disease in China: Beijing and Shanghai. Chin J Dig Dis 2000; 16: 2081-8.
6. Wang J H, Luo J Y, Dong L et al. Epidemiology of gastroesophageal reflux disease: A general pupulation-based study in Xi'an of Northwest China. World J Gastroenterol 2004; 10: 1647-51.
7. Yeh C, Hsu C T, Ho A S et al. Erosive esophagitis and Barrett's esophagus in Taiwan: A higher frequency than expected. Dig Dis Sci 1997; 42: 702-6.
8. Wong W M, Lam S K, Hui W M et al. Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese-prevalence and spectrum of the disease. Aliment Pharmacol Ther 2002; 16: 2037-42.
9. Goh K L, Chang S C, Fock K M et al. Gastro-oesophageal reflux disease in Asia. J Gastroenterol Hepatol 2000; 15: 230-8.
10. Wang L D, Zheng S, Zheng Z Y et al. Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: In special reference to China. World J Gastroenterol 2003; 9: 1156-64.
11. Hongo M, Shoji T. Epidemiology of reflux disease and CLE in East Asia. J Gastroenterol 2003; 38: 25-30.
12. Rosaida M S, Goh K L. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: A prospective, endoscopy based study. Euro J Gastroentro Hepatol 2004; 16: 495-501.
13. Goh K L. Changing epidemiology of gastroesophageal reflux disease in the Asian-Pacific region: An overview. J Gastroenterol Hepatol 2004; 19: 22-5.
14. Pan G Z, Xu G M, Guo H P et al. An epidemiologic study on symptomatic GER in Beijing and Shanghai. Chin J Dig 1999; 19: 223-6. (Chinese).
15. Fujimoto K, Iwakiri R, Okamoto K et al. Characteristics of gastroesophageal reflux disease in Japan: Increased prevalence in elderly women. J Gastroenterol 2003; 38: 3-6.
16. Wang L D, Guo R F, Fan Z M et al. Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. Dis Esophagus 2005; 18: 177-84.
17. Wang L D, Zheng S, Liu B et al. GSTs and mEH polymorphisms and susceptibility to esophageal carcinoma: Study of population from a high-incidence area in north China. World J Gastroenterol 2003; 9: 1394-7.
18. Kihara M, Noda K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis 1995; 16: 2331-6.
19. Hayes J D, Pulford D J. The glutathine S-transferases suspergene familay: Regulation of GST and contributions of the isoenzymes to cancer chemoprevention and drug resistance. Crit Rev Biochem Mol Biol 1995; 31: 445-600.
20. Seidegarrd J, Pero R W, Miller D G et al. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 1986; 7: 751-3.
21. Pemble S, Schroeder K R, Spenser S R et al. Human glutathione S-transferaseθ (GSTT1): CDNA coloning and the characterization of a genetic polymorphism. Biochem J 1994; 300: 271-6.
22. Esther M M, Hennie M J. Polymorphic expression of the Glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma. Cancer Res 1999; 59: 586-9.
23. Klauser A G, Schindlbeck N E, Muller-Lissner S A. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335: 205-8.
24. Chinese Gastroesophageal Reflux Disease Study Group. The value of reflux diagnostic questionnaires in the diagnosis of gastroesophageal reflux disease. Chin J Dig 2003; 23: 651-4.
25. Armstrong D, Bennett J R, Blum A L et al. The endoscopic assessment of oesophagitis: A progress report on observer agreement. Gastroenterology 1996; 111: 85-92.
26. Riddell R H. The biopsy diagnosis of gastroesophageal reflux disease, 'carditis', and Barrett's esophagus, and sequelae of therapy. Am J Surg Pathol 1996; 20: S31-50.
27. Goh K L, Parasakthi N, Peh S C et al. The rapid urease test in the diagnosis of Helicobacter pylori infection. Singapore Med J 1994; 35: 161-2.
28. Gao S S, Fan Z M, Zhuang Z H et al. Analysis on helicobacter pylori (Hp) infection in pylori from symptom-free subjects at high-incidence area for esophageal cancer in Henan. J Zhengzhou Univ (medical science) 2002; 37: 785-7. (Chinese).
29. Van Lieshout E M, Roelofs H M, Dekker S et al. Polymorphic expression of the glutathione S-Transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma. Cancer Res 1999; 59: 586-9.
30. Shaheen N, Ransohoff D F. Gastroesophageal reflux, Barrett's esophagus, and esophageal cancer: Scientific review. JAMA 2002; 287: 1972-81.
31. Wang L D, Qin Y R, Fan Z M et al. Comparative genomic hybridization: comparison between esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from the patients at high-incidence area for both esophageal and gastric cardia cancers in Henan, northern China. Dis Esophagus 2006 (in press).